309 related articles for article (PubMed ID: 33926403)
21. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
[TBL] [Abstract][Full Text] [Related]
22. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial.
Adubra L; Alber D; Ashorn P; Ashorn U; Cheung YB; Cloutman-Green E; Diallo F; Ducker C; Elovainio R; Fan YM; Gates L; Gruffudd G; Haapaniemi T; Haidara F; Hallamaa L; Ihamuotila R; Klein N; Luoma J; Martell O; Sow S; Vehmasto T;
Trials; 2023 Jan; 24(1):5. PubMed ID: 36597115
[TBL] [Abstract][Full Text] [Related]
23. Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Gaynor BD
Pediatr Infect Dis J; 2018 Jun; 37(6):506-510. PubMed ID: 29088030
[TBL] [Abstract][Full Text] [Related]
24. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
[TBL] [Abstract][Full Text] [Related]
25. Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.
Oldenburg CE; Ouattara M; Bountogo M; Boudo V; Ouedraogo T; Compaoré G; Dah C; Zakane A; Coulibaly B; Bagagnan C; Hu H; O'Brien KS; Nyatigo F; Keenan JD; Doan T; Porco TC; Arnold BF; Lebas E; Sié A; Lietman TM
JAMA; 2024 Feb; 331(6):482-490. PubMed ID: 38349371
[TBL] [Abstract][Full Text] [Related]
26. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
[TBL] [Abstract][Full Text] [Related]
27. Morbidity in a Longitudinal Cohort of Children Residing in Villages Randomized to Biannual Treatment With Azithromycin Versus Placebo.
West SK; Bloch E; Weaver J; Munoz B; Mrango Z; Kasubi M; Lietman T; Coles C
Clin Infect Dis; 2020 Feb; 70(4):574-580. PubMed ID: 30950493
[TBL] [Abstract][Full Text] [Related]
28. A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol.
ABCD study team
Trials; 2020 Jan; 21(1):71. PubMed ID: 31931848
[TBL] [Abstract][Full Text] [Related]
29. Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.
Amza A; Yu SN; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Gaynor BD; Keenan JD; Porco TC; Lietman TM
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3128. PubMed ID: 25210836
[TBL] [Abstract][Full Text] [Related]
30. Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trial.
Arzika AM; Maliki R; Amza A; Karamba A; Gallo N; Aichatou B; Sara II; Beidi D; Haroun LM; Oumarou F; Lebas E; Peterson B; Colby E; Nguyen W; Liu Z; Fitzpatrick MC; Arnold BF; Lietman TM; O'Brien KS;
PLOS Glob Public Health; 2023; 3(11):e0002559. PubMed ID: 37967058
[TBL] [Abstract][Full Text] [Related]
31. Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger.
Platts-Mills JA; Ayoub EG; Zhang J; McQuade ETR; Arzika AM; Maliki R; Abdou A; Keenan JD; Lietman TM; Liu J; Houpt ER
Clin Infect Dis; 2022 Aug; 75(3):515-518. PubMed ID: 35020888
[TBL] [Abstract][Full Text] [Related]
32. Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali.
Luoma J; Adubra L; Alber D; Ashorn P; Ashorn U; Cloutman-Green E; Diallo F; Ducker C; Elovainio R; Fan YM; Gates L; Gruffudd G; Haapaniemi T; Haidara F; Hallamaa L; Ihamuotila R; Klein N; Martell O; Sow S; Vehmasto T; Cheung YB
Trials; 2023 Nov; 24(1):733. PubMed ID: 37968741
[TBL] [Abstract][Full Text] [Related]
33. Safety of azithromycin in infants under six months of age in Niger: A community randomized trial.
Oldenburg CE; Arzika AM; Maliki R; Kane MS; Lebas E; Ray KJ; Cook C; Cotter SY; Zhou Z; West SK; Bailey R; Porco TC; Keenan JD; Lietman TM;
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006950. PubMed ID: 30419040
[TBL] [Abstract][Full Text] [Related]
34. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
[TBL] [Abstract][Full Text] [Related]
35. Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.
Arzika AM; Maliki R; Goodhew EB; Rogier E; Priest JW; Lebas E; O'Brien KS; Le V; Oldenburg CE; Doan T; Porco TC; Keenan JD; Lietman TM; Martin DL; Arnold BF;
Nat Commun; 2022 Feb; 13(1):976. PubMed ID: 35190534
[TBL] [Abstract][Full Text] [Related]
36. Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger.
Arzika AM; Maliki R; Boubacar N; Kane S; Cook CA; Lebas E; Lin Y; O'Brien KS; Austin A; Keenan JD; Lietman TM; Oldenburg CE; For The Mordor Study Group
Am J Trop Med Hyg; 2020 Sep; 103(3):1315-1318. PubMed ID: 32067628
[TBL] [Abstract][Full Text] [Related]
37. Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
Arzika AM; Maliki R; Abdou A; Mankara AK; Harouna AN; Cook C; Hinterwirth A; Worden L; Zhong L; Chen C; Ruder K; Zhou Z; Lebas E; O'Brien KS; Oldenburg CE; Le V; Arnold BF; Porco TC; Keenan JD; Lietman TM; Doan T
Clin Infect Dis; 2021 Oct; 73(7):1292-1295. PubMed ID: 34037753
[TBL] [Abstract][Full Text] [Related]
38. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
[TBL] [Abstract][Full Text] [Related]
39. Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7-11 Years.
Brennhofer SA; Rogawski McQuade ET; Zhang J; Pholwat S; Stroup S; Platts-Mills JA; Liu J; Houpt ER
Am J Trop Med Hyg; 2023 Feb; 108(2):428-432. PubMed ID: 36535258
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
